Amazon and Eli Lilly Partner for Telehealth Medication Delivery Amid Drug Shortages
March 13, 2024
Amazon has partnered with Eli Lilly to distribute select medications, including GLP-1 drugs Mounjaro and Zepbound, through LillyDirect, enhancing home delivery access for diabetes, obesity, and migraine treatments. This collaboration addresses consumer demand and drug shortages, particularly Lilly’s diabetes medication, Mounjaro. The partnership boosts Lilly’s efforts to improve medication access, contributing to a significant revenue increase, with Mounjaro alone generating over $2.2 billion in a quarter. Amazon’s foray into healthcare and prescription drug delivery continues, evidenced by this deal and initiatives like a $35 insulin coupon and the RxPass subscription service for generic drugs. Despite previous setbacks in the healthcare sector, Amazon’s consistent efforts, including the acquisition of PillPack and the launch of Amazon Pharmacy, signal its ambition to redefine pharmacy experiences and healthcare delivery.
To read more, click here.
[Source: MM+M, March 13th, 2024]
